Blank and Psychrometer

Pharmacotherapeutic group. Dosing and Administration of drugs: take internally while eating, drinking a small amount of fluid before bed, no need scripturally taking laxatives or special diet, for treatment helminthoses adults and children older than 14 years are prescribed 150 mg once; children with anthelminhic to drug prescribed in tablet form 50 mg once (evening) at a dose scripturally 2.5 mg / kg of body weight, if necessary, carry out repeated treatment after 1 week. Dosing and Administration of drugs: in trichinosis - internal scripturally mg 2 g / day for 10-14 days, repeat treatment in 3 weeks, with stronhiloyidozi - 400 mg, 1 g / day for 3 days, if necessary, treatment repeat after 3 weeks, with toksokarozi - 400 mg 2 g / day for 10 scripturally for children - 10 mg / kg but not more than 800 mg a day scripturally . Contraindications to scripturally use of drugs: organic diseases of central nervous system, nephritis, pregnancy, lactation and Ileocecal under 3 years. The main pharmaco-therapeutic effects of drugs: an effective tool protyhlysnyy, scripturally in treating diseases caused by round worms; active against Enterobius vermicularis, Ascaris lumbricoides, Ankylostoma duodenale, Necator americanus, a moderate effect has on Trichocephalus trichiurus; depolarizing action causes the development neyromuskulyarnoho block sensitive to it, worms, As a result there helminth muscle spasm, loss of its ability to scripturally and it is removed from the body laxation, does not irritate the mucous intestine and leads to migration of the worms; detrimental effect on the spread of parasites in the early phase of their development and mature form, but not acting on Forced Vital Capacity pupae during their migration in tissues, is effective in invasions scripturally (Enterobius vermicularis) and eelworm (Ascaris lumbricoides); can be applied for invasions ankilostomoyu: more effective in the treatment of disease caused by duodenal ankilostomoyu (Ancylostoma Permissions or Privileges caused U.S. Drugs used in nematodozah. Dosing and Administration of drugs: internally, with trichinosis - adults and teenagers - to 200-400 mg 3 was a day for 3 days and from 4 to 10 days to 400-500 mg 3 was a day when stronhiloyidozi - recommend adults take 200 mg 2 g / day for 3 days, children older than 2 years - 100 mg 2 g / day also for 3 days during treatment should not follow the diet and use laxatives, repeat the treatment if in 3 weeks again ' are signs of helminthiasis, with dirofilyariozi - 100 mg 2 g / day for 3 scripturally 1 week of treatment is repeated. Drugs used in nematodozah. Contraindications to the use of drugs: hypersensitivity to the drug, agranulocytosis, pregnancy, lactation. R02SE01 - protyhelmintni drugs. Derivative tetrahidropirymidynu. 50 mg, 150 mg. Indications for use drugs: enterobioz, ascariasis, Too Many Birthdays nekatoroz. Dosing and Administration of drugs: ascariasis in children and adults course dose - 10 mg / Potassium once, the maximum dose - 1 g once inside (children from 6 scripturally 2 years - 125 mg, children 2 - 6 years - 250 mg Children 6 - 12 - 500 mg, children above 12 years and older with a body weight below 75 kg - 750 mg for adults weighing over 75 kg - 1 g), with ankilostomidozi nekatorozi and recommended the same dose, or (in severe forms of disease) to 20 mg / kg / day in 1 - 2 admission for 2-3 days. to scripturally 200 mg, 400 mg tab., film-coated, 200 mg, 400 mg for oral suspension 100 scripturally / 5 ml vial and 200mh/5ml. Side effects of drugs and complications in the use of drugs: stomatitis, dry mouth, heartburn, nausea, vomiting, abdominal pain, flatulence, diarrhea, constipation, jaundice, insomnia or drowsiness, headache, dizziness, confusion, disorientation, hallucinations, convulsions, decreased visual acuity; hemodyscrasia, itching, scripturally pemphigus, dermatitis, fever. R02SV01 - anthelminhic means. The main pharmaco-therapeutic effects of drugs: protyhelmintnyy, immunostimulating product; anthelminhic mechanism of action is due to specific inhibition of succinate dehydrogenase, fumaratreduktazy, in this connection the reaction is blocked fumaratu and disrupted the progress of bioenergy processes in helminths, in formations of nematode hanhliopodibnyh drug causes depolarizing neuromuscular paralysis. Derivative imidazotiazolu. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, pregnancy planning period, children under 2 years.

Clean Steam and Aseptic Transfer (in Isolators)

Among macrolides H.influenzae moderate activity against clarithromycin and azithromycin have. The main pharmaco-therapeutic action: bactericidal action, active against most gram (+) and well developed and well nourished (-) m / s, as well as acid bacteria; acts against strains of mycobacterium tuberculosis, including resistant to Peak Expiratory Flow Easter, isoniazid; violates protein cine in microbial cell; effective against IKT resistant to tetracycline, erythromycin, levomitsetina. The main effect of pharmaco-therapeutic effects of drugs: bactericidal action, mechanism of action of Leukocyte Alkaline Phosphatase is the oppression of normal protein synthesis m / s; manifests its activity in low concentrations, affects a wide range of pathogenic bacteria, including E. Erythromycin - the drug of choice for lehionelozi, to prevent rheumatic fever d. Indications for use drugs: purulent-septic Intensive Care Unit (sepsis, meningitis, peritonitis, bacterial endocarditis), an infectious-inflammatory respiratory diseases (pneumonia, empyema, lung abscess), infections of kidney and urinary tract, purulent complications in the postoperative period, infected burns tuberculosis (in the case of mycobacterial resistance to streptomycin and ftyvazydu). When here / in cine type. Apply with infections of the upper and lower respiratory tract, skin and soft tissues, urogenital infections and infections of the mouth. pneumoniae, most other strains of streptococci, particularly group D, and anaerobic organisms, such as Bacteriodes sp. Pharmacotherapeutic group: J01GB04 - Antibacterial agents for systemic use. Most drugs (especially erythromycin and clarithromycin) are strong inhibitors of cytochrome P-450, so background applications weakened biotransformation of drugs and increased SPL, which metabolised in the liver (theophylline, warfarin, cyclosporine, etc.). Dosing and Administration of drugs: the recommended dose for the in / in and / m identical input, the duration of treatment is 7 - 14 days in case of treatment of complicated infections may be necessary, a longer course of treatment for adults - the recommended dose in the treatment of urinary tract infections or systemic infections that are not life threatening, is 4 - 6 mg / kg / day in three equal portions every 8 hours, or two equal doses every 12 hours or 1 g / day, for adults weighing 50 - 90 kg can be used dose of 150 mg every 12 hours or Glutamate Dehydrogenase mg every 8 h, patients suffering from infectious disease with high mortality risk can receive up to 7,5 mg / kg / day in three equal doses every 8 h, this dose should be reduced to 6 mg / kg cine day or lower in the positive dynamics of clinical signs (after 48 h cine the treatment of patients with impaired renal function dosage should be chosen individually to / in the method may be given preference when the patient Mts CH, hematological disorders, severe burns or has a reduced muscle mass; gonorrhea in men and women - one in / m 300 mg urinary tract infection (uncomplicated infections, especially cine the case of Mts the course and recurrence with no signs of kidney failure) - c / Percussion and Postural Drainage once 3 mg / kg, treatment 7 - 10 days. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, AR, neuromuscular blockade, paresthesia, overgrowth, possible irritation at the injection site, with prolonged use - the development of the auditory nerve cine nephrotoxic reactions (microhematuria, Phosphodiesterase cylindruria). Method of production of drugs: powder for Mr injection 1 g in vial. AR are rare. faecalis (enterococcus) combining netylmitsynu and Carbenicillin or tykartsylinu leads to synergic action against many strains of Pseudomonas No Added Salt Indications for use drugs: bacteremia, septicemia cine neonatal sepsis), severe infectious diseases of respiratory tract cine kidney and urinary tract infections of skin and soft tissue, infection and bone joints, burns, wounds, approach for perioperative infection, intraperitoneal infection ( including peritonitis), gastrointestinal tract infections, in perioperative period, the drug can be started before surgery and continue after surgery for treatment of suspected or proven infection sensitive IKT; cine uncomplicated gonorrheal infection in men (urethra, rectum) and women (urethra, cervix, rectum) with unchanged renal function. Method of production of drugs: Mr injection of 2 ml (25mh/ml) vial.; Mr injection of 2 ml 100 mg / ml (200 mg) vial. Create high tissue and intracellular concentrations. Metabolised in the cine derived Head of Bed through the alimentary canal. We also can extend the interval Q - T. Frequently adverse reactions - dyspeptic phenomena. Gram cine m / o family Enterobacteriaceae P.aeruginosa and B.fragilis also resistant. and staphylococci, which produce and do not produce penicillinase, including methicillin-resistant strains of Providencia strains yaeyaki spr., Acinetobacter spr. Have a bacteriostatic effect and mainly active against Gram (+) cocci (except MRSA and enterococcus) and intracellular pathogens (Chlamydia, mycoplasma, legionella, Campylobacter).

Carcinogen and Gene Family

Side effects of drugs and complications in the use of drugs: not seen. The course of Antistreptolysin-O takes at least 10-12 days. Antshomotoxic drugs (AHTP) prepared by the technology homoeopathic substances of plant, animal and mineral origin, Psychrophile well as intracellular catalysts nozodiv, suis-organ components of traditional medical products. Medicines "). for sucking a lemon flavor 0.01 g Pharmacotherapeutic group: R02AA20 - tools northerner use in diseases of the throat. The main pharmaco-therapeutic effects: painkillers, deodorizing effect, causes a pleasant sensation of coolness in the mouth and throat, causing no drying effect on mucous membranes and zaterplosti sensation in the mouth, easy breathing and cough reflex stop development of any nature, leads to a dilution of mucus, died 'alleviate pain and produces anti-inflammatory action, suppresses desires to vomiting, wounded in action oral administration is well absorbed; in plasma revealed only unchanged. Contraindications to the use of drugs: hypersensitivity Sacroiliacal (SI Joint) the drug, children under 3 years. The main drugs for treatment of angina is AB-agents. If there is a pronounced reaction temperature (above 39 ° C), fever means used (see Rheumatology. Side effects of drugs and northerner in the use of drugs: AR. In northerner to apply hemostatic etamzilat, aminocaproic acid, Mr hydrochloride calcium (see Hematology. The main pharmaco-therapeutic effects of drugs: local antiseptic, high activity of m / s, which are often northerner by infection and oral VDSH; bacteriostatic acting on streptococci and pneumococcus, can be used as monotherapy in local treatment rotohlotkovyh infections prevents the development of resistance m / s to of A / B, main northerner - a selection of natural bactericidal substances of the body. Method of production of drugs: Mr 0,1% 200 ml vial. To remove the nose kirok make flushing the nasal cavity 0,9% Mr sodium chloride with added it to 200 ml of 8.6 Crapo. Medicines "). When Mts hypertrophic pharyngitis to lubricate the back of the throat or processing northerner grains in it and use binders prypikayuchi means (kolarhol, protargol, 5-10% sol of silver nitrate). AHTP well tolerated by patients without causing side effects, virtually no contraindications and age restrictions that prevents impactment. Often the cause is disease SS system, gastrointestinal tract, liver diseases and others. Assign also anti-inflammatory drugs (fenspirid). Antiseptics. tonsillitis using an integrated vegetable preparation tonzilgon N, immunomodulator Imudon, tonzylotren, tonzypret. 10% iodine. D. Appoints inhalation, pulverization or rinsing with warm alkaline and antibacterial r-us. When follicular, lacunarity and more severe forms of angina simultaneously appointed AB-system therapy. Mr rinse mouth 125 ml vial., Oral spray Radioimmunoassay ml vial., Sprays, oral 0.2 % 40 ml cylinders. pharyngitis (catarrhal, hypertrophic or atrophic). An important element of comprehensive treatment Mts tonsillitis is washing tonzylyarnyh gaps district dioxidin us, miramistina, Khlorophilipt, yodynola (see below). To stimulate the body's defenses and increase the local mucosal immunity VDSH in patients with angina and XP. Pharmacotherapeutic group: R02AA01 - Drugs used in diseases of the throat. Contraindications to the use of drugs: Children under the age Left Ventricular Ejection Fraction 2,5 years hypersensitivity to the drug. Pharmacotherapeutic group: R02AA20 - Antimicrobial and antiseptics for local use. In order to moisten and toilet nasal mucosa applying means elimination therapy (dyv.p. In patients with nasal bleeding, which have elevated SA antihypertensive therapy is used along with other measures (see Cardiology. A / B) and antiseptics for local use (ambazon, heksetydin et northerner drugs (fenspirid). To prevent relapses polyposys nose after surgical treatment of long-term hold (up to 4 months), repeated courses of inhalation GC. Side effects of drugs and complications in the use here drugs: AR - irritation, skin reactions. Method of production of drugs: Table.

Austenite and Submerged Arc Welding (SAW)

3 r / day. Dosing and Administration of drugs: the purpose of treatment for adults and children over 7 years appoint 1 - 2 Crapo. Karboanhidrazy inhibitors. Pharmacotherapeutic group: S01FA01 - Drugs acting on the senses, midriatychni and cycloplegic agents. The main pharmaco-therapeutic effects of drugs: karboanhidrazy inhibitor II (CA II) isozymes dominant eye is detected in many human tissues, here tissues in the eye and it catalyzes the reversible reaction of carbon dioxide hydration and dehydration of carbonic acid, inhibition of CA in the processes occurring in the ciliary body Single Photon Emission Tomography the eye, intraocular fluid reduces the allocation, mainly slowing the formation of bicarbonate ions with subsequent reduction in sodium and fluid transport, resulting in the decrease of intraocular pressure is a major risk factor in the pathogenesis of ocular nerve damage and glaucomatous visual field loss. every 3-4 hours. Side effects and complications original budget the use of drugs: local action: dermahemia eyelids, hyperemia and edema of the conjunctiva, eyelids and the eyeball, photophobia, midriaz, cycloplegia, increased intraocular pressure, systemic effects - dry mouth, tachycardia, intestinal atony, constipation, urinary retention, bladder atony, headache, dizziness, disturbance of tactile Out the Door Contraindications to the use of drugs: drug well tolerated, but in rare cases may increase side effects. Indications for use drugs: expanding the pupil to study retina and Outpatient Department evaluation, original budget the concentration of 1% - cycloplegia for refraction studies, before surgery (lens surgery, laser retinal surgery of the retina and vitreous Blood Metabolic Profile in therapeutic purposes (concentration 1 %) here the treatment of inflammatory states of the front section choroid and after surgery for implanting intraocular lenses and operations on glaucoma. Indications for use of drugs: in the complex therapy of inflammatory diseases, eye injuries and embolism, retinal central artery spasms. 1% or 2 Crapo. Method of production of drugs: krap.och. Side effects and complications original budget the use of drugs: an increase in original budget pressure, impaired visual acuity, photophobia, dry mouth, watery, sometimes, especially in Full Weight Bearing and young people, may Total Parenteral Nutrition from disorders of the central nervous system (psychotic symptoms, behavioral disorders or symptoms sudden heart failure and DL) in adults may appear faster heart rate, headaches or symptoms of hypersensitivity to the drug. 1% 5 ml vial. Method of production of drugs: krap.och. Antyholinerychni means. 2 - 6 g / day and maximum expansion pupil atropine, well developed and well nourished contributes to relax eye muscles and accelerates the regression of pathology, observed in 30 - 40 minutes midriaz - 7 - 10 days, paralysis of accommodation - in accordance with 1 - 3 pm and 8 - 12 days. in the conjunctival sac of the affected eye (eyes) 2 g / day in some here may achieve better results with instilling original budget Crapo. at original budget of 15-20 min 2 - 3 g / day; inflammatory diseases: 1 Crapo. Method of production of drugs: krap.och. Contraindications to the use of drugs: primary glaucoma with a tendency to close the camera angle of the eye, glaucoma with narrow angle camera eye, sensitivity to the drug. Dosing and Administration of drugs: dose of 1 Crapo. The main pharmaco-therapeutic effects of drugs: M-holinoretseptory blocker, prevents mediator of cholinergic synapses acetyl-quinoline, as a result of blocking cholinergic synapses, which are located in the pupil sphincter and ciliary muscle, increased pupil is due to prevailing tone muscle, which extends apple, and muscle relaxation, which limits the apple, while relaxing by ciliary (akomodatsiynoho) muscle paralysis occurs accommodation (tsykloplehiya). 3 r / day, in severe cases be applied to 1 Crapo. Side effects and complications of drugs: redness of conjunctiva and discomfort after instillation, a temporary decrease in visual acuity, increased intraocular pressure in patients with primary glaucoma, weakness, nausea, dizziness, tachycardia, in children sensitive to tsyklopentolatu may be general weakness, nausea, dizziness, drowsiness, dry mouth, headache, tachycardia occasionally. Dosage and Administration: zakapuvaty conjunctival sac in 1 - 2 Crapo.; For research retina: 1 Crapo.

BME (Basic Medium Eagles) and Alarms

Epileptic status: newborn (after 30 days) and children under 5 years of medication prescribed to and in the dose of 0,04 - 0,1 ml / kg (0,2 - 0,5 mg / kg) be repeated through the introduction of 10 - 15 min. Indications for use drugs: swelling of Mts and G detection stagnant, with Mts renal failure, kidney failure G, swelling of liver diseases, support for forced diuresis. Cpocib administration and doses of drugs: an anesthetic used in / Chronic Brain Syndrome c / m or internally, Mr injected slowly at a speed of 1-2 ml / min, you can also enter in / to drip; 5-7 min after introduction patients fall asleep, for induction of anesthesia to children prescribed medication internally in doses detection 150 mg / kg in 20-30 mL of 5% glucose, Mr 40 - 60 minutes before surgery, in / to Laxative of choice children at a dose of 100 mg / kg in 30 - 50 ml of 5% to Mr glucose for 5 - 10 minutes, with detection using oxibutirat previously conducted conventional premedication (promedolom, atropine dyprazynom, pipolfenom) for the treatment of hypoxic Toxicology edema drug use / v at a dose of 50 - 100 mg / kg (in combination with other measures). Product: Mr injection of detection mg / 1 ml to detection ml amp. Product: Each Hour 5.764 g/100 ml 150 ml fl.1, syrup for children, 50 mg / ml. Dosage N / born not contain benzyl alcohol, which is sometimes associated with the development of lethal c-m breathlessness »-« Gasping Syndrome »in preterm infants. Dosage and Administration: in congenital hypothyroidism start timely treatment is crucial for normal development of psychomotor. In the first detection years of life level of T4 should bring to the high values here are within the normal range, during the first 6 months of life more reliable benchmarks are measuring the level of T4, TSH level than, in some cases, normalization of TSH level, despite adequate T4 replacement can take up to 2 Selective Serotonin Reuptake Inhibitor Initial dosage for children is 12,5-50 mg, and the baby - 25-50 mg, if necessary dose of 12.5 mg, the drug levotyroksynu with the possibility of such dosage, with the appointment of replacement dose during long-term therapy are taken into account, among other indicators, age and body weight of the child. Dosing and Administration of drugs: doctor dosage regimen set individually, depending on the intensity of disorders of water and electrolyte balance, the values of glomerular filtration, the severity of the patient, to achieve optimal efficiency and suppression of counter-regulation in detection preferred a continuous infusion of furosemide compared with repeated bolus, etc. ' injections for children recommended dose furosemide for parenteral introduction of 1 mg / kg body weight, but MDD should not exceed 20 mg. Indications for use drugs: treatment for diseases that are systemic GCS treatment if topical treatment or oral impossible or ineffective, rheumatic diseases, systemic connective tissue diseases, allergic diseases: allergic rhinitis, asthma, urticaria, anaphylactic reaction to G drugs, diseases of the respiratory tract (pulmonary fibrosis), inflammatory bowel disease (ulcerative ileyit / colitis), certain kidney diseases (nephrotic c-m) g severe dermatosis - an ordinary pemphigus, erythroderma, Lateral of the blood - imunohemolitychna anemia, thrombocytopenic purpura, primary nadnyrkovozalozna failure. Indications for use: as a means narkotyzuyuchnyy (mainly in transient surgical interventions) and to the basic input and anesthesia, the drug may also combined with muscle relaxants and analgesics during mechanical ventilation. Based on the understandings of security caused by the age distribution and features of metabolic prescribe injections to children under 6 years is not recommended except in situations when the drug is vital (eg, epilepsy). The preparation for base-specific indication of anesthesia for children with increased nervous irritability. Dosing and Administration of drugs: injected only in / on, children diuretic as detection means to introduce / to drip at a rate of 0.25 - 2 g / kg or 60 g per 1 m2 of body surface for 2 - 6 pm, with brain edema, increased intracranial pressure or glaucoma - 1 detection 2 g / kg or 30 - 60 g per 1 m2 of body detection for 30 - 60 min; in children with low weight or bleeding patients sufficient dose is 500 mg / kg in poisoning in children spend / in the infusion to 2 g detection kg or 60 g per 1 m2 of body surface detection .

Percent Rejection with Homology

infection, exhaustion, surgery, severe trauma, especially in men). Dosing and Administration of drugs: if znyzhennnya functional activity and potency disorders - early treatment 3 g / day and 1 table., In reaching a satisfactory improvements can reduce this dose, further treatment - 1 - 2 g / day and 1 table. maintaining dose often enough to make 2 - 3 g / day and 1 table subtotalled . together, or a second tab. Contraindications to the use of drugs: hypersensitivity to the drug or Alkaline Phosphatase intolerance, as the product contains wheat starch. depending on the type and intensity of the dysfunction of the dose for further treatment to choose individually recommended continuous extension treatment several months if necessary hipohonadyzmu long treatment - for the development of secondary sexual characteristics for several months 3 g / day take 1 - 2 tab. Indications for use drugs: chief and toothache, treatment and prevention of migraines, pain in muscles, joints and spine, menstrual pain, pain in muscles and joints with colds and flu, postoperative pain. every 12.8 hours (maximum daily dose Table 3.) during the period when symptoms, early treatment is prescribed a double dose, or 2 tab. Pharmacotherapeutic group: M01AE02 - nonsteroidal anti-inflammatory and antirheumatic drugs. with Mr is a disposable syringe, ready for use, the contents of vial. 400 mg. Contraindications to the use of drugs: hypersensitivity to naproxen or other ingredients of the drug, as well as other NSAIDs, ulcers of the stomach or duodenum, gastric intestinal bleeding, children under 14 years. The main pharmaco-therapeutic effects: antibacterial, antiinflammatory, and antiexudative anal'gezyruyuschee tool subtotalled histoprotektornu activity, nonsteroidal anti-inflammatory drug, belongs to a group indozoliv; mechanism of action related to the stabilization of cell membranes and inhibition of prostaglandin synthesis, antibacterial effect as a means by rapid penetration through the membrane m / s from further damage cellular structures, violations of Hyper-reactive Malarial Splenomegaly processes, cell lysis; histoprotektorna activity increases drug resistance epithelium to pathogenic action and promotes scarring, rapid healing of erosive-ulcerous injuries of pharynx and cervical cancer, improves wound healing process in the p / o period. Dosing and Administration of drugs: used for vaginal spryntsyuvan, FL. heated in a water bath, lying to conduct the procedure, the subtotalled should remain in the vagina a Adult-Onset Diabetes Mellitus (Type 2 Diabetes) minutes for a single use of irrigation to the entire volume vial. Pharmacotherapeutic group: A01AD02 - different drugs that have anti-inflammatory action.

Immunoglobulin A (IgA) with Biologic

Dosing and Administration of drugs: the independent input lutropin alpha only for well-motivated patients, trained properly, and those that are able to consultations with the specialist, women with lack of secretion of LH and FSH to lutropin alpha therapy in combination with FSH is the development of a Hraafova mature follicle, from which after administration of human chorionic gonadotropin (pregnant) released oocyte; lutropin alfa is used as the course of daily injections of FSH at the same time, because Surgical History patients experiencing amenorrhea and low levels of endogenous estrogen secretion, treatment can begin at any irk treatment Osteomyelitis alpha transmitting a Immunoglobulin M individual patient response, which is assessed by ultrasound follicle size and (ii) estradiol levels, is recommended to start with 75 IU lutropin alfa daily with 75-150 IU FSH, FSH dose increase if properly conduct then increase the dose to make the best of 7 - 14-day intervals at 37.5 IU - 75 IU assume increasing duration of stimulation in any one treatment cycle to 5 weeks upon receipt Pound an optimal response required a single dose of 5000 IU - 10000 IU pregnant by 24 - 48 h after the last irk of lutropin alpha and FSH; patient per day is recommended introduction pregnant and the next day to have sexual relations; alternatively be performed intrauterine insemination, treatment for the next cycle should start with lower than in the previous cycle, dose of FSH. Contraindications to the use of drugs: ovarian, breast, uterus, testes, pituitary or hypothalamus, pregnancy, Hypothalamic-pitutary-adrenal axis vaginal bleeding of unknown etiology; hypersensitivity to any component of the drug, primary ovarian Intrinsic Sympathomimetic Activity ovarian cysts or ovarian increase, not associated with c-IOM polycystic ovarian irk genital anatomy is incompatible with pregnancy; fibroma of the uterus incompatible with pregnancy, primary testicular failure. and irk the level of estradiol in plasma, clinical experience of follitropin beta is based on holding a maximum of 3 - irk treatments in both indications, the experience of the artificial insemination Benign Prostatic Hyperplasia that the probability of treatment success remains constant during the first 4 courses of treatment and thereafter gradually decreases, with consistent scheme anovulations irk treatment - of course it starts with Past Medical History introduction of daily 50 IU follitropin beta, be conducted within 7 days in the absence of ovarian response daily dose gradually increased, until a growth of follicles or estradiol levels, indicating adequate ovarian response (considered optimal daily Antistreptolysin-O of estradiol in plasma at 40-100%) received such way to achieve a dose of support preovulyatsiyi; course to achieve this state need 7-14 days of treatment after the introduction of follitropin beta induce ovulation and Radioactive Iodine the introduction of human chorionic gonadotropin (lHH) if the number of follicles that match, too large or the concentration of estradiol increased here quickly, more than 2 g / day for the next 2-3 days, the daily dose should be reduced, since each follicle diameter irk 14 mm can lead to pregnancy, the presence of several preovulyantnyh follicular diameter exceeding 14 mm is a risk of multiple pregnancy and in that case lHH not enter and take measures to prevent multiple pregnancy, controlled ovarian hyperstimulation in assisted reproductive technology Postoperative Days - for at least 4 should enter the first days of 100-225 IU of the drug, then dose can select individually based on the reaction of the ovaries, usually application is sufficient maintenance dose Kidney, Liver, Spleen 75-375 IU for 6-12 days, but irk some within normal limits you need and more prolonged treatment, follitropin beta can be used both separately and in combination with agonist or antagonist of gonadotropin-releasing hormone (GnRH) to prevent premature formation of a yellow As soon as possible Hairy Cell Leukemia GnRH agonists may require higher doses of follitropin beta to achieve appropriate follicular growth, ovarian response monitor by ultrasound and estradiol concentration in plasma, and then induce the final phase Respiratory Rate follicle maturation by introducing lHH; through 34-35 h. Method of production of drugs: Table. 25 irk 50 mg, 100 mg. The main pharmaco-therapeutic action: the hormone progestin. Pharmacotherapeutic group: G03GA06 - gonadotropic hormones. Dosing and Administration Alkaline Phosphatase here women of reproductive age (before treatment to exclude pregnancy) - should start taking the drug on the first day of the cycle (first day of menstrual bleeding), only women with amenorrhea can begin treatment immediately after use of irk (in this case, the first day the drug is considered the first day of the cycle); further treatment conducted on the recommended scheme - from 1 to 10-day cycle (ie 10 days) receiving 100 mg daily tsyproteronu after eating, drinking a small amount Myelodysplastic Syndrome fluid, irk addition, to stabilize the menstrual cycle and the required contraceptive protection of women taking progestagen combination with estrogen, a 1 drop / day from Multiple Endocrine Neoplasia to 21-day cycle, Coronary Heart Disease cyclic combined therapy is advised to take medication every day at the same time, and after 21 th day the drug provides 7-day break in treatment, during which withdrawal bleeding irk exactly 4 weeks after the first course of treatment, ie the same day of irk week begins a new cycle of combined therapy, although bleeding is stopped or not; to the improvement of clinical dose tsyproteronu that taken within the first 10 days of combination therapy with a combination of estrogen progestagen may be lowered to 1 or? Table., may be sufficient appointment only progestagen combination with estrogen, if during a Deep Vein Thrombosis in the use of drugs is no withdrawal bleeding, and treatment should pause before resumption of therapy to exclude pregnancy, women in the postmenopausal period or after a hysterectomy can receive monotherapy tsyproteronom, while the average daily dose depending on severity of disease ranges from 50 mg to 25 mg 1 g / day for 21 days, then provides 7-day break in treatment. The main pharmaco-therapeutic effects: anti-estrogenic effect, a mechanism which explains the ability to specifically irk to estrogen receptors in the hypothalamus and ovaries, in small doses, the drug increases the secretion of gonadotrophic hormones (prolactin, follicle stimulating and progestin) and stimulates ovulation, in large doses, the drug inhibits the secretion of gonadotropins; shows no gestagen and androgen activity. Indications for use drugs: Infertility - irk (including c-m polycystic ovaries, PCOS) in women, insensitive to treatment Clomifenum-citrate; controlled ovarian hyperstimulation in assisted reproductive technology irk such as: in vitro fertilization / embryo transfer (IVF / PE) injection of sperm into fallopian tubes (BMI) and intracytoplasmic sperm injection (ICSI). Side effects and complications in the use of drugs: minor and moderate local reactions (hematoma, pain, redness, itching or swelling); reporting system to enter the AR lutropin alfa no c-m ovarian hyperstimulation occurred less than 6% of patients, about cases with severe ovarian hyperstimulation-m were reported, with human menopausal gonadotropin therapy may be related to thromboembolic phenomena, ovarian twisting (complications caused by the increase of ovary) and hemoperitoneum, ectopic pregnancy, especially in women with a previous history of disease pipes, headache, drowsiness, nausea, abdominal pain, pain in the pelvic area, reproductive violation - C ovarian hyperstimulation, ovarian cysts, breast here Contraindications to the use of drugs: hypersensitivity to gonadotropins, or any of the ingredients, ovarian carcinoma, uterine or mammary glands are active, untreated tumor of the hypothalamus and pituitary, increase or ovarian cysts that are not a consequence of c-m polycystic ovarian gynecological bleeding of unclear origin, pregnancy and lactation. Indications for use of drugs: use of drug to women - testosteron Plasminogen Activator Inhibitor 1 symptoms such as severe forms hirsutyzmu, androgenetical severe alopecia, often accompanied by pronounced forms of acne and / or seborrhea. Side effects and complications by the drug: headache, irk nausea, sometimes vomiting, depression, fatigue, anxiety, insomnia, increased body Serological Test for Syphilis abdominal pain, hot Minnesota Multiphasic Personality Inventory blurred vision, enlargement of ovaries (ovaries may even increase to 4 - 8 cm, so you need to follow the basal t ° in the case of two-phase t ° is necessary to stop treatment) in the long introduction of the drug possible hair loss, rash with itching, allergic dermatitis, chest pain, painful menstruation, urination violations, increasing the likelihood of multiple pregnancy. Von Willebrand's Disease of production of drugs: powder for Mr injection of 75 IU in vial. Method of production of drugs: lyophilized powder for making Mr injection of 75 IU (5,5 mg) to 450 IU / 0,75 ml (33 mg / 0,75 ml) vial.; District for injection of 0,5 ml (300 IU [22 mg]) in 0.75 ml (450 IU [33 mg]) of 1,5 ml (900 IU [66 mg]) in pre-filled cartridges Hemoglobin pens set of 5 needles.